Vorinostat in Treating Patients With Relapsed or Refractory Advanced Hodgkin's Lymphoma

Clinical trial NCT00132028 · COMPLETED

Trial details

NCT number: NCT00132028
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adult Favorable Prognosis Hodgkin Lymphoma Adult Lymphocyte Depletion Hodgkin Lymphoma Adult Lymphocyte Predominant Hodgkin Lymphoma Adult Mixed Cellularity Hodgkin Lymphoma Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma Adult Nodular Sclerosis Hodgkin Lymphoma Adult Unfavorable Prognosis Hodgkin Lymphoma Recurrent Adult Hodgkin Lymphoma

Start date: 2005-09-01
Primary completion: 2009-05-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.